References
- Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca 2+ channel gene CACNL1A4. Cell. 1996;87(3):543–552.
- Gilmore B, Michael M. Treatment of acute migraine headache. Am Fam Physician. 2011;83(3):271–280.
- Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.
- Antonaci F, Ghiotto N, Wu S, et al. Recent advances in migraine therapy. Springerplus. 2016;5(1):637.
- Çelik Y, Ekuklu G, Tokuç B, et al. Migraine prevalence and some related factors in Turkey. Headache. 2005;45(1):32–36.
- Lewis D, Ashwal S, Hershey A, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents report of the American academy of neurology quality standards subcommittee and the practice committee of the child neurology society. Neurology. 2004;63(12):2215–2224.
- FDA. RELPAX® - FDA 2002 [cited 2020 20.03.2020].
- Takiya L, Piccininni LC, Kamath V. Safety and efficacy of eletriptan in the treatment of acute migraine. Pharmacother J Human Pharmacol Drug Ther. 2006;26(1):115–128.
- Kastan MB. DNA damage responses: mechanisms and roles in human disease: 2007 GHA clowes memorial award lecture. Mol Cancer Res. 2008;6(4):517–524.
- Attia SM, Ashour AE, Bakheet SA. Comet‐FISH studies for evaluation of genetic damage of citalopram in somatic cells of the mouse. J Appl Toxicol. 2013;33(9):901–905.
- Bonassi S, El-Zein R, Bolognesi C, et al. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Mutagenesis. 2011;26(1):93–100.
- Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protoc. 2007;2(5):1084.
- Dusinska M, Collins AR. The comet assay in human biomonitoring: gene–environment interactions. Mutagenesis. 2008;23(3):191–205.
- Norizadeh Tazehkand M, Topaktas M. The in vitro genotoxic and cytotoxic effects of remeron on human peripheral blood lymphocytes. Drug Chem Toxicol. 2015;38(3):266–271.
- Ila HB, Ilhan A. In vitro genotoxic perspective of Tamiflu. Cytotechnology. 2012;64(4):443–449.
- Hassanane MS, Hafiz N, Radwan W, et al. Genotoxic evaluation for the tricyclic antidepressant drug, amitriptyline. Drug Chem Toxicol. 2012;35(4):450–455.
- Vandghanooni S, Eskandani M. Comet assay: a method to evaluate genotoxicity of nano-drug delivery system. Bioimpacts. 2011;1(2):87.
- Rozgaj R, Kašuba V, Brozović G, et al. Genotoxic effects of anaesthetics in operating theatre personnel evaluated by the comet assay and micronucleus test. Int J Hyg Environ Health. 2009;212(1):11–17.
- Ündeğer Ü, Başaran N. Effects of pesticides on human peripheral lymphocytes in vitro: induction of DNA damage. Arch Toxicol. 2005;79(3):169–176.
- Feng S, Kong Z, Wang X, et al. Assessing the genotoxicity of imidacloprid and RH-5849 in human peripheral blood lymphocytes in vitro with comet assay and cytogenetic tests. Ecotoxicol Environ Saf. 2005;61(2):239–246.
- He J, Chen W, Jin L, et al. Comparative evaluation of the in vitro micronucleus test and the comet assay for the detection of genotoxic effects of X-ray radiation. Mutat Res Genet Toxicol Environ Mutagen. 2000;469(2):223–231.
- Kirsch-Volders M, Sofuni T, Aardema M, et al. Report from the in vitro micronucleus assay working group. Mutat Res Genet Toxicol Environ Mutagen. 2003;540(2):153–163.
- Eastmond DA, Tucker JD. Identification of aneuploidy‐inducing agents using cytokinesis‐blocked human lymphocytes and an antikinetochore antibody. Environ Mol Mutagen. 1989;13(1):34–43.
- Lorge E, Hayashi M, Albertini S, et al. Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test: I. Theoretical aspects. Mutat Res Genet Toxicol Environ Mutagen. 2008;655(1):1–3.
- Tice RR, Agurell E, Anderson D, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 2000;35(3):206–221.
- Fenech M. The in vitro micronucleus technique. Mutat Res. 2000;455(1):81–95.
- Aldemir E, Akdeniz F. Effects of valproate on male reproductive functions. Turk J Psychiatry. 2009;20:4.
- Gras J, Llenas J, Jansat JM, et al. Almotriptan, a new anti‐migraine agent: A review. CNS Drug Rev. 2002;8(3):217–234.
- Khan S, Ahmad T, Parekh CV, et al. Investigation on sodium valproate induced germ cell damage, oxidative stress and genotoxicity in male Swiss mice. Reprod Toxicol. 2011;32(4):385–394.
- Krogenaes AK, Taubøll E, Stien A, et al. Valproate affects reproductive endocrine function, testis diameter and some semen variables in non-epileptic adolescent goat bucks. Theriogenology. 2008;70(1):15–26.
- Villarini M, Dominici L, Piccinini R, et al. Assessment of primary, oxidative and excision repaired DNA damage in hospital personnel handling antineoplastic drugs. Mutagenesis. 2010;26(3):359–369.
- Villarini M, Moretti M, Pasquini R, et al. In vitro genotoxic effects of the insecticide deltamethrin in human peripheral blood leukocytes: DNA damage (‘comet’assay) in relation to the induction of sister-chromatid exchanges and micronuclei. Toxicology. 1998;130(2–3):129–139.
- Collins AR, Dobson VL, Dušinská M, et al. The comet assay: what can it really tell us? Mutat Res. 1997;375(2):183–193.
- OECD. Guidance Document on Revisions to OECD Genetic Toxicology Test Guidelines. OECD Workgroup of National Coordinators for Test 42 Guidelines (WNT). 2015.
- Kim YK, Shin K-H, Alderman J, et al. Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects. Drug Des Devel Ther. 2018;12:331.